Abstract

Root canal therapy linked to pulpal diseases or trauma is common in modern dental care. The 2% Lidocaine which is considered as the gold standard has some drawbacks in pulpal anaesthesia. Ropivacaine has beneficial anaesthetic effects on pulpal anaesthesia. Therefore, it is of interest to compare and evaluate the pulpal aesthetic effect using 0.5% Ropivacaine and 2% Lidocaine in symptomatic irreversible pulpitis. A double blinded randomized controlled clinical trial consisting of 110 lower molar and premolar tooth with irreversible pulpitis cases for root canal therapy were selected and randomly divided into 2 groups. Group A: 2% lidocaine with epinephrine and Group B: 0.5% ropivacaine. The pulp sensibility tests with heat test, cold test and electric pulp test were completed. The preoperative pain score was measured with Visual Analogue Scale (VAS) pain scale. The classical inferior alveolar nerve block (IANB) technique was administered to all patients by a single operator. Subjects were asked for lip numbness and presence or absence of lip numbness. Postoperative pain scores were recorded during access opening and on placing files in the canal. There is no statistical difference between the groups during pre operative conditions. The mean pain scores within group A and group B is recorded. The difference was found to be statistically significant with p value ≤ 0.05. Significant difference between the mean values after and before the treatment is observed. However, there is no statistical significance between the mean pain scores between the access and pulp. The 0.5% Ropivacaine and 2% Lidocaine with epinephrine does not have any significant difference during access opening. However, 0.5% Ropivacaine groups were effective while placing the file in the canal. Thus, 0.5% Ropivacaine showed better results even though it was not statistically significant for further consideration in this context.

Highlights

  • Pulpal inflammation may or may not be associated with toothache, which will be recognized as acute and chronic pulpitis based on the duration of the condition

  • Ropivacaine belongs to the group of local anesthetics, the pipecoloxylidides and it has a propyl group on the piperidine nitrogen atom when compared to bupivacaine, which has a butyl group

  • We show that the 2% Lidocaine with epinephrine group had 90.9 % of lip numbness and 0.5% Ropivacaine had 94.5% of lip numbness after anesthesia

Read more

Summary

Introduction

Pulpal inflammation may or may not be associated with toothache, which will be recognized as acute and chronic pulpitis based on the duration of the condition. The localized increase in tissue fluid pressure associated with acute inflammation usually results in toothache Search for a long‐acting local anesthetic agent continues for effective pain control for treatment of irreversible pulpitis [1,2,3,4,5,6]. The inferior alveolar nerve block technique (IANB), which commonly has high failure, rates, in patients with irreversible pulpitis [3,7]. Studies in patients with irreversible pulpitis have reported failure rates with IANB of 44–81% [8,9,10] due to activated nociceptors in an inflamed pulp, which leads to a decrease in pain threshold and decreased efficacy of the IANB [11]. It is of interest to document the comparative evaluation of 0.5% ropivacaine and lidocaine as dental pulp anaesthesia

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call